July 20, 2026
Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY
July 20, 2026
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
July 14, 2026
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
July 8, 2026
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
July 6, 2026
Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential
July 2, 2026
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
July 1, 2026
Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
June 22, 2026
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening
June 15, 2026
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
June 3, 2026
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
Pagination